Keywords: Developing countries, developing world genomics, essential medicines, genomics and international development, global personalized medicine, pharmacogenomics and primary care, primary care genomics, public health pharmacogenomics
No takes yet. Share an insight, caveat, or question.
Bartlett et al. (2012) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: